According to Fortune Business Insights, the global leukapheresis market share was valued at USD 621.4 million in 2025 and is projected to reach USD 1,059.3 million by 2034, expanding at a CAGR of 6.0% during the forecast period. North America dominated the leukapheresis market with a share of 36.71% in 2025, supported by advanced healthcare infrastructure, increasing adoption of cell-based therapies, and growing prevalence of hematological disorders and cancer treatments.
Leukapheresis is a medical procedure used to separate and collect white blood cells from blood for therapeutic treatments, research, and cell therapy applications. The procedure plays a critical role in stem cell transplantation, immunotherapy, CAR-T cell therapy, and treatment of blood-related disorders. Increasing advancements in apheresis technologies and rising demand for personalized medicine are significantly driving market growth globally.
MARKET DYNAMICS
Market Drivers
Rising Demand for Cell and Gene Therapies
Increasing adoption of CAR-T cell therapy, stem cell transplantation, and immunotherapy treatments is driving demand for leukapheresis procedures worldwide.
Market Restraints
High Cost of Apheresis Equipment and Procedures
Advanced leukapheresis systems and associated treatment procedures involve substantial costs, limiting adoption in certain healthcare settings.
Market Opportunities
Technological Advancements in Automated Apheresis Systems
Innovations in automated cell separation technologies and improved blood component collection systems are creating strong market opportunities.
Market Challenges
Limited Availability of Skilled Healthcare Professionals
Leukapheresis procedures require specialized technical expertise and trained healthcare professionals, posing operational challenges for healthcare providers.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/leukapheresis-market-115796
LEUKAPHERESIS MARKET TRENDS
Increasing Adoption of Leukapheresis in Immunotherapy and Regenerative Medicine
Healthcare institutions and research organizations are increasingly using leukapheresis technologies for cell therapy manufacturing, regenerative medicine, and oncology treatments.
SEGMENTATION ANALYSIS
By Product Type
The market includes instruments and consumables. Consumables dominate the market due to recurring demand for disposable kits, tubing sets, and collection components during leukapheresis procedures.
By Procedure Type
Procedures include donor leukapheresis and therapeutic leukapheresis. Therapeutic leukapheresis dominates the market due to increasing use in treatment of leukemia, autoimmune disorders, and blood-related diseases.
By Technology Platform
Technology platforms include centrifugation, membrane filtration, and others. Centrifugation dominates the market due to its high efficiency and widespread use in blood component separation procedures.
By End User
End users include hospitals, specialty clinics, blood collection centers & blood banks, and others. Hospitals dominate the market due to high patient volumes, advanced treatment capabilities, and increasing adoption of cell-based therapies.
REGIONAL ANALYSIS
North America
North America dominates the market due to strong healthcare infrastructure, increasing adoption of advanced cell therapies, and rising investments in biotechnology and cancer research.
Europe
Europe is witnessing steady growth driven by increasing research activities in regenerative medicine and rising demand for stem cell therapies.
Asia Pacific
Asia Pacific is expected to grow rapidly due to expanding healthcare infrastructure, increasing awareness regarding advanced therapies, and rising healthcare investments.
Latin America
Latin America is experiencing gradual growth supported by improving healthcare services and increasing adoption of advanced blood treatment technologies.
Middle East & Africa
The Middle East & Africa region is witnessing moderate growth due to increasing healthcare modernization and rising awareness regarding advanced therapeutic procedures.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/leukapheresis-market-115796
COMPETITIVE LANDSCAPE
- Terumo Blood and Cell Technologies
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co., Ltd.
- Miltenyi Biotec
- Cerus Corporation
- Macopharma SA
- Baxter International Inc.
- Nikkiso Co., Ltd.
- B. Braun Melsungen AG
REPORT COVERAGE
The leukapheresis market report provides insights into market size, segmentation, regional outlook, and competitive landscape. It highlights trends such as automated apheresis systems, cell therapy applications, regenerative medicine advancements, and immunotherapy-driven demand. Increasing focus on personalized medicine, stem cell research, and advanced oncology treatments is expected to drive market growth during the forecast period.